Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Overview BPC-157 is a synthetic peptide studied in a range of experimental and regenerative research settings
As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
In controlled laboratory research environments, NNMT activity is associated with nicotinamide metabolism, cellular energy balance, and biochemical signaling networks
Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
You can make repeated withdrawals from the bottle to reconstitute or dilute the peptides
Over 100 published preclinical studies have demonstrated protective and reparative effects of BPC-157 across tendon, muscle, bone, and gastrointestinal tissue
US$ 28.02
US$ 22.39
US$ 26.85
US$ 23.60
US$ 29.50
